S2 guideline for diagnosis and treatment of infectious endocarditis;S2-Leitlinie zur diagnostik und therapie der infektiösen endokarditis

Zeitschrift fur Kardiologie

Volumn 93, Issue 12, 2004, Pages 1005-1021

  Naber, Christoph K ^a,b   Bauhofer, Artur ^a   Block, Michael ^a   Buerke, Michael ^a   Erbel, Raimund ^a   Graninger, Wolfgang ^a   Herrmann, Mathias ^a   Horstkotte, Dieter ^a   Kern, Peter ^a   Lode, Hartmut ^a   Mehlhorn, Uwe ^a   Meyer, Jürgen ^a   Mügge, Andreas ^a   Niebel, Jörg ^a   Peters, Georg ^a   Shah, Pramod M ^a   Werdan, Karl ^a  

^a DGK ^*

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; ERYTHROMYCIN; FLUCYTOSINE; GENTAMICIN; ISOXAZOLE DERIVATIVE; METICILLIN; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULTAMICILLIN; TEICOPLANIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ANAMNESIS; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; BACTERIUM CULTURE; BIOPSY; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE COURSE; ECHOCARDIOGRAPHY; ENDOCARDITIS; ENTEROCOCCUS; GRAM POSITIVE BACTERIUM; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MONOTHERAPY; PENICILLIN RESISTANCE; PRACTICE GUIDELINE; REVIEW; STREPTOCOCCUS; VASCULAR SURGERY;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; DOCUMENTATION; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; EVIDENCE-BASED MEDICINE; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HUMANS; PATIENT CARE TEAM; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE;

EID: 19944428326     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-004-0183-0     Document Type: Review

References (108)

1. Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch F (2002) Association pour l'Etude et la Prevention de l'Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288:75-81
2. Benetka O, Block M, Sangha O, Praetorius F, Gottwik M, Uebis R, Neuhaus KL, v Essen R (1999) On behalf of the ALKK, Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte. Clinical course of infective endocarditis in the late nineties: preliminary results of the ALKK endocarditis registry [abstract]. Eur Heart J 20(suppl):362
3. Horstkotte D (2004) For the Task Force on Infective Endocarditis of the European Society of Cardiology. Recommendations for Prevention, Diagnosis and Treatment of Infective Endocarditis. Eur Heart J 25:267-276
4. Lorenz W, Ollenschläger G, Geradts M, Gerlach FM, Grandjour A, Helou A (2001) Das Leitlinien-Manual. Entwicklung und Implementierung von Leitlinien in der Medizin. Zeitschrift für ärztliche Fortbildung und Qualitätssicherung. 95/1. Auflage
5. The AGREE-Collaboration (2003) Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument http://www.agreecollaboration.org
6. Trappe, HJ (2003) Leitlinien der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung. Z Kardiol 92:689-693
7. Delbecq AL, Van de Ven AH, Gustafson DH (1975) Group techniques for program planning. Glenview, IL, Scott, Foresman and Company
8. Evangelista A, Gonzalez-Alujas MT (2004) Echocardiography in infective endocarditis. Heart 90:614-617
9. Mügge A (1993) Echocardiographic detection of cardiac valve vegetations and prognostic implications. Infect Dis Clin North Am 7:877-898
10. Erbel R, Rohmann S, Drexler M, Mohr-Kahaly S, Gerharz CD, Iversen S, Oelert H, Meyer J (1988) Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study. Eur Heart J 9:43-53
11. Daniel WG, Mugge A, Martin RP, Lindert O, Hausmann D, Nonnast-Daniel B, Laas J, Lichtlen PR (1991) Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 324:795-800
12. Piper C, Hetzer R, Korfer R, Bergemann R, Horstkotte D (2002) The importance of secondary mitral valve involvement in primary aortic valve endocarditis; the mitral kissing vegetation. Eur Heart J 23:79-86
13. Di Salvo G, Habib G, Pergola V, Avierinos JF, Philip E, Casalta JP, Vailloud JM, Derumeaux G, Gouvernet J, Ambrosi P, Lambert M, Ferracci A, Raoult D, Luccioni R (2001) Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 37:1069-1076
14. Rohmann S, Erbel R, Darius H, Gorge G, Makowski T, Zotz R, Mohr-Kahaly S, Nixdorff U, Drexler M, Meyer J (1991) Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr 4:465-474
15. Mügge A, Daniel WG, Frank G, Lichtlen PR (1989) Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 14:631-638
16. Mügge A (2001) Management of imminent emboli in endocarditis: are they predictable? Herz 26:391-397
17. Weinstein MP (1996) Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis 23:40-46
18. Shah PM, Ullmann U, Seifert H, Trautmann M, Briedigkeit H, Gross RJ, Jansen B, Kern WV, Reinert RR, Rosenthal EJK, Roth B, Salzberger B, Schrappe M, Spencker FB, von Stockhausen HB, Steinmetz T, A'Ashi J (1997) Sepsis Blutkulturdiagnostik. MiQ 3:1-44
19. Morris AJ, Drinkovic D, Pottumarthy S, Strickett MG, MacCulloch D, Lambie N, Kerr AR (2003) Gram Stain, Culture, and Histopathological Examination Findings for Heart Valves Removed because of Infective Endocarditis Clin Infect Dis 36:697-704
20. Chuard C, Antley CM, Reller LB (1998) Clinical utility of cardiac valve Gram stain and culture in patients undergoing native valve replacement. Arch Pathol Lab Med 122:412-415
21. Brouqui P, Raoult D (2001) Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 14:177-207
22. Goldenberger D, Kunzli A, Vogt P, Zbinden R, Altwegg M (1997) Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol 35:2733-2739
23. Lisby G, Gutschik E, Durack DT (2002) Molecular methods for diagnosis of infective endocarditis. Infect Dis Clin North Am 16:393-412
24. Bosshard PP, Kronenberg A, Zbinden R, Ruef C, Bottger EC, Altwegg M (2003) Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience. Clin Infect Dis 37:167-172
25. Millar B, Moore J, Mallon P, Xu J, Crowe M, Mcclurg R, Raoult D, Earle J, Hone R, Murphy P (2001) Molecular diagnosis of infective endocarditis - a new Duke's criterion. Scand J Infect Dis 33:673-680
26. Lepidi H, Durack DT, Raoult D (2002) Diagnostic methods current best practices and guidelines for histologic evaluation in infective endocarditis. Infect Dis Clin North Am 16:339-361, ix
27. Murdoch DR (2003) Diagnosis of Legionella infection. Clin Infect Dis 36:64-69
28. Durack DT, Lukes AS, Bright DK (1994) New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96:200-209
29. Naber CK, Erbel R (2003) Diagnosis of culture negative endocarditis: novel strategies to prove the suspect guilty. Heart 89:241-243
30. Habib G, Derumeaux G, Avierinos JF, Casalta JP, Jamal F, Volot F, Garcia M, Lefevre J, Biou F, Maximovitch-Rodaminoff A, Fournier PE, Ambrosi P, Velut JG, Cribier A, Harle JR, Weiller PJ, Raoult D, Luccioni R (1999) Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol 33:2023-2029
31. Kupferwasser LI, Darius H, Muller AM, Martin C, Mohr-Kahaly S, Erbel R, Meyer J (2001) Diagnosis of culture-negative endocarditis: the role of the Duke criteria and the impact of transesophageal echocardiography. Am Heart J 142:146-152
32. Rognon R, Kehtari R, Francioli P (1999) Individual value of each of the Duke criteria for the diagnosis of infective endocarditis. Clin Microbiol Infect 5:396-403
33. Uh Y, Shin DH, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY (2004) Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea. J Antimicrob Chemother 53:1095-1097
34. Stein DS, Nelson KE (1987) Endocarditis due to nutritionally deficient streptococci: therapeutic dilemma. Rev Infect Dis 9:908-916
35. Karchmer AW, Moellering RC Jr, Maki DG, Swartz MN (1979) Single-antibiotic therapy for streptococcal endocarditis. JAMA 241:1801-1806
36. Francioli P, Etienne J, Hoigne R, Thys JP, Gerber A (1992) Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA 267:264-267
37. Wilson WR, Thompson RL, Wilkowske CJ, Washington JA, Giuliani ER, Geraci JE (1981) Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin. JAMA 245:360-363
38. Sexton DJ, Tenenbaum MJ, Wilson WR, Steckelberg JM, Tice AD, Gilbert D, Dismukes W, Drew RH, Durack DT (1998) Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. Clin Infect Dis 27:1470-1474
39. Malakoff RF, Frank E et al (1979) Streptococcal endocarditis: single vs combination therapy JAMA 241:1807-1810
40. Tan JS, Kaplan S, Terhune CA Jr, Hamburger M (1971) Successful two week schedule for penicillin-susceptible S. viridans endocarditis. Lancet 2:1340-1343
41. Roberts SA, Lang SR (1993) Short course treatment of penicillin- susceptible viridans streptococcal endocarditis with penicilline and gentamicin. Inf Dis Clin Pract 2:191-194
42. Woolfe JC, Johnson WD (1974) Penicilline-sensitive streptococcal endocarditis: in vitro and clinical observations on penicillin-streptomycin therapy. Ann Int Med 81:178-181
43. Perillo JE, Porst, MH et al (1979) Endocarditis due to resistent viridans streptoccoci during dental penicillin prophylaxis NEJM 300:296-300
44. Friedberg LK, Rosen KM et al (1968) Vancomycin therapy for enterococcal and S.viridans endocarditis. Arch Int Med 122:134
45. Wilson AP, Gaya H (1996) Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases. J Antim Chemoth 38:507-521
46. Presterl E, Graninger W, Georgopoulos A (1992) The efficacy of teicoplanin in the treatment of endocarditis caused by gram-positive bacteria J Antimicrobial Chemother 31:755-766
47. Kresken M, Hafner D (1999) Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975-1995. Study Group Bacterial Resistance of the Paul-Ehrlich-Society for Chemotherapy. Infection 27(Suppl2): S2-S8
48. Fruden TR, Munriff SS (1993) Emergence of vancomycin-resistant endocarditis in New York City. Lancet 342:76
49. Babcock HM, Ritchie DJ, Christiansen E, Starlin R, Little R, Stanley S (2001) Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid. Clin Infect Dis 32:1373-1375
50. Thompson RL, Lavin B, Talbot GH (2003) Endocarditis due to vancomycin-resistant Enterococcus faecium in an immunocompromised patient: cure by administering combination therapy with quinupristin/dalfopristin and high-dose ampicillin. South Med J 96:818-820
51. Patterson JE, Sweeney AH, Simms M, Carley N, Mangi R, Sabetta J, Lyons RW (1995) An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine (Baltimore) 74:191-200
52. Wilson WR, Wilkowski CJ et al (1984) Treatment of streptomycin susceptible and streptomycin resistant enterococcal endocarditis. Ann Int Med 100:816-823
53. Schmit JL (1992) Efficiency of tei-complanin for enterococcal infection: 63 cases and review. Clin Infect Dis 15:302-306
54. Westenfelder GO, Peterson PJ et al (1973) Vancomycin-streptomycin synergism in enterococcal endocarditis JAMA 223:37-40
55. Chambers HF, Korzeniowski OM, Sande MA (1983) Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts. Medicine (Baltimore) 62:170-177
56. Witte W, Braulke C, Cuny C, Heuck D, Kresken M (2001) Changing pattern of antibiotic resistance in methicillin-resistant Staphylococcus aureus from German hospitals. Infect Control Hosp Epidemiol 22:683-686
57. Staphylococcus aureus resistant to vancomycin-United States (2002) MMWR Morb Mortal Wkly Rep 51:565-567
58. Small PM, Chambers HF (1990). Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 34:1227-1231
59. Korzeniowski O, Sande MA (1982) Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Ann Intern Med 97:496-503
60. Karchmer AW, Archer GL, Dismukes WE (1983) Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis. Rev Infect Dis 5(Suppl 3):S543-S548
61. Archer GL, Johnston JL, Vazquez GJ, Haywood HB III (1983) Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: in vitro and in vivo studies. Rev Infect Dis 5(Suppl 3):S538-S542
62. Lucet JC, Herrmann M, Rohner P, Auckenthaler R, Waldvogel FA, Lew DP (1990) Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 34:2312-2317
63. Rouse MS, Wilcox RM, Henry NK, Steckelberg JM, Wilson WR (1990) Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother 34: 273-276
64. Karchmer AW, Archer GL, Dismukes WE (1983) Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiological and clinical observations as guides to therapy. Ann Int Med 98:447-453
65. Vandenesch F, Etienne J, Reverdy ME, Eykyn SJ (1993) Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin Infect Dis 17:871-876
66. Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, Bisno AL, Ferrieri P, Shulman ST, Durack DT (1995) Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 274:1706-1713
67. Wieland M, Lederman MM, Kline-King C, Keys TF, Lerner PI, Bass SN, Chmielewski R, Banks VD, Ellner JJ (1986) Left-sided endocarditis due to Pseudomonas aeruginosa. A report of 10 cases and review of the literature. Medicine (Baltimore) 65:180-189
68. Reyes MP, Brown WJ, Lerner AM (1978) Treatment of patients with pseudomonas endocarditis with high dose aminoglycoside and carbenicillin therapy. Medicine (Baltimore) 57:57-67
69. Fantin B, Farinotti R, Thabaut A, Carbon C (1994) Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa. J Antimicrob Chemother 33:563-569
70. Pefanis A, Giamarellou H, Karayiannakos P, Donta I (1993) Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis. Antimicrob Agents Chemother 37:308-313
71. Geraci JE, Wilson WR (1982) Symposium on infective endocarditis. III. Endocarditis due to gram-negative bacteria. Report of 56 cases. Mayo Clin Proc 57:145-148
72. Ellis ME, Al Abdely H, Sandridge A, Greer W, Ventura W (2001) Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis 32:50-62
73. Donal E, Abgueguen P, Coisne D, Gouello JP, McFadden EP, Allal J, Corbi P (2001) Echocardiographic features of Candida species endocarditis: 12 cases and a review of published reports. Heart 86:179-182
74. Muehrcke DD, Lytle RW (1995) Surgical an long term antifungal therapy for fungal prosthetic valve endocarditis. Ann Thorac Surg 60:538-543
75. Duroux-Vouilloz C, Praz G, Francioli P, Peter O (1998) Q-fever endocarditis, clinical presentation and serological follow-up of 21 patients. SMW 128:740-744
76. Jacobs F, Abramowicz D, Vereerstraeten P, Le Clerc JL, Zech F, Thys JP (1990) Brucella endocarditis: the role of combined medical and surgical treatment. Rev Infect Dis 12:740-744
77. Raoult D, Fournier PE, Drancourt M, Marrie TJ, Etienne J, Cosserat J, Cacoub P, Poinsignon Y, Leclercq P, Sefton AM (1996) Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med 125:646-652
78. Siegman-Igra Y, Kaufman O, Keysary A, Rzotkiewicz S, Shalit I (1997) Q-fever endocarditis in Israel and a world wide review. Scand J Infect Dis 29:41-49
79. Sanchez-Recalde A, Mate I, Lopez E, Yebra M, Merino JL, Perea J, Tellez A, Sobrino JA (2000) Coxiella Burneti endocarditis: long-term clinical course in 20 patients Rev. Espanol Cardiol 53:940-946
80. Drancourt M, Mainardi JL, Brouqui P, Vandenesch F, Carta A, Lehnert F, Etienne J, Goldstein F, Acar J, Raoult D (1995) Bartonella (Rochalimaea) quintana endocarditis in three homeless men. N Engl J Med 332:419-423
81. Raoult D (1999) Afebrile blood culture-negative endocarditis. Ann Intern Med 131:144-146
82. Saravolatz LD, Burch KH, Quinn EL, Cox F, Madhavan T, Fisher E (1978) Polymicrobial infective endocarditis: an increasing clinical entity. Am Heart J 95:163-168
83. Chambers HF, Miller RT, Newman MD (1988) Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med 109:619-624
84. Ribera E, Gomez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez-Alujas T, Almirante B, Ocana I, Pahissa A (1996) Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ann Intern Med 125:969-974
85. Heldman AW, Hartert TV, Ray SC, Daoud EG, Kowalski TE, Pompili VJ, Sisson SD, Tidmore WC, vom Eigen KA, Goodman SN, Lietman PS, Petty BG, Flexner C (1996) Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 101:68-76
86. Niebel J (1991) Infective Endocarditis in immune-compromised patients. In: Horstkotte D, Bodnar E (eds) Current Issues in Heart Valve Disease: Infective Endocarditis. ICR Publishers, London, p 154-163
87. Nahass RG, Weinstein MP, Bartels J, Gocke DJ (1990) Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients. J Infect Dis 162:967-970
88. Pulvirenti JJ, Kerns E, Benson C, Lisowski J, Demarais P, Weinstein RA (1996) Infective endocarditis in injection drug users: importance of human immunodeficiency virus serostatus and degree of immunosuppression. Clin Infect Dis 22:40-45
89. Francioli P, Etienne J, Hoigne R, Thys JP, Gerber A (1992) Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA 267:264-267
90. Stamboulian D, Bonvehi P, Arevalo C, Bologna R, Cassetti I, Scilingo V, Efron E (1991) Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. Rev Infect Dis 13(Suppl 2): S160-S163
91. Tornos P, Almirante B, Mirabet S, Permanyer G, Pahissa A, Soler-Soler J (1999) Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med 159:473-475
92. Chan KL, Dumesnil JG, Cujec B, Sanfilippo AJ, Jue J, Turek MA, Robinson TI, Moher D (2003) Investigators of the Multicenter Aspirin Study in Infective Endocarditis. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 42:775-780
93. Netzer RO, Altwegg SC, Zollinger E, Tauber M, Carrel T, Seiler C (2002) Infective endocarditis: determinants of long term outcome. Heart 88:61-66
94. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM (2004) Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858-873
95. DiDomenico RJ, Park HY, Southworth MR, Eyrich HM, Lewis RK, Finley JM, Schumock GT (2004) Guidelines for acute decompensated heart failure treatment. Ann Pharmacother. 38:649-660
96. Graupner C, Vilacosta I, SanRoman J, Ronderos R, Sarria C, Fernandez C, Mujica R, Sanz O, Sanmartin JV, Pinto AG (2002) Periannular extension of infective endocarditis. J Am Coll Cardiol 39:1204-1211
97. Choussat R, Thomas D, Isnard R, Michel PL, Iung B, Hanania G, Mathieu P, David M, du Roy dC, de Gevigney G, Le Breton H, Logeais Y, Pierre-Justin E, de Riberolles C, Morvan Y, Bischoff N (1999) Perivalvular abscesses associated with endocarditis; clinical features and prognostic factors of overall survival in a series of 233 cases. Perivalvular Abscesses French Multicentre Study. Eur Heart J 20:232-241
98. Rohmann S, Seifert T, Erbel R, Jakob H, Mohr-Kahaly S, Makowski T, Gorge G, Oelert H, Meyer J (1991) Identification of abscess formation in native-valve infective endocarditis using transesophageal echocardiography: implications for surgical treatment. Thorac Cardiovasc Surg 18: 353-359
99. Chan KL (2002) Early clinical course and long-term outcome of patients with infective endocarditis complicated by perivalvular abscess. CMAJ 167:19-24
100. Rohmann S, Erbel R, Darius H, Makowski T, Meyer J (1997) Effect of antibiotic treatment on vegetation size and complication rate in infective endocarditis. Clin Cardiol 20: 132-140
101. Vilacosta I, Graupner C, San Roman JA, Sarria C, Ronderos R, Fernandez C, Mancini L, Sanz O, Sanmartin JV, Stoermann W (2002) Risk of embolization after institution of antibiotic therapy for infective endocarditis.: J Am Coll Cardiol. 39:1489-1495
102. Empfehlungen der ständigen Impfkommission am Robert-Koch-Institut (STIKO). http://www.rki.de/
103. Horstkotte D, Schulte HD, Niehues R, Klein RM, Piper C, Strauer BE (1993) Diagnostic and therapeutic considerations in acute, severe mitral regurgitation: experience in 42 consecutive patients entering the intensive care unit with pulmonary edema. J Heart Valve Dis 2:212-222
104. Horstkotte D, Piper C, Wiemer M, Arendt G, Steinmetz H, Bergemann R, Schulte HD, Schultheiß HP (1998) Emergency heart valve replacement after acute cerebral embolism during florid endocarditis. Med Klein 15: 284-293
105. Chastre J, Trouillet JL (1995) Early infective endocarditis on prosthetic valves. Eur Heart J 16(Suppl B):32-38
106. Piper C, Körfer R, Horstkotte D (2001) Prosthetic valve endocarditis. Heart 85:590-593
107. Hagl C, Galla JD, Lansman SL, Fink D, Bodian CA, Spielvogel D, Griepp RB (2002) Replacing the ascending aorta and aortic valve for acute prosthetic valve endocarditis: is using prosthetic material contraindicated? Ann Thorac Surg 74:S1781-S1785
108. Lytle BW, Sabik JF, Blackstone EH, Svensson LG, Pettersson GB, Cosgrove DM III (2002) Reoperative cryopreserved root and ascending aorta replacement for acute aortic prosthetic valve endocarditis. Ann Thorac Surg 74:S1754-S1757